Formosa Pharmaceuticals (TPE:6838) ROCE % : -7.59% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Formosa Pharmaceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Formosa Pharmaceuticals's annualized ROCE % for the quarter that ended in Dec. 2024 was -7.59%.

Formosa Pharmaceuticals ROCE % Historical Data

The historical data trend for Formosa Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Pharmaceuticals ROCE % Chart

Formosa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-47.37

-73.01

-54.89

-25.98

-10.58

Formosa Pharmaceuticals Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial											-11.40	-0.06	-27.57	-10.90	-7.59

Formosa Pharmaceuticals ROCE % Calculation

Formosa Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-179.005	/	( ( (1726.781 - 257.979)	+	(2112.272 - 197.951) )	/ 2 )
	=	-179.005	/	( (1468.802	+	1914.321)	/ 2 )
	=	-179.005	/	1691.5615
	=	-10.58 %

Formosa Pharmaceuticals's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-147.184	/	( ( (2149.839 - 187.471)	+	(2112.272 - 197.951) )	/ 2 )
	=	-147.184	/	( ( 1962.368	+	1914.321 )	/ 2 )
	=	-147.184	/	1938.3445
	=	-7.59 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Formosa Pharmaceuticals (TPE:6838) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Formosa Pharmaceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Formosa Pharmaceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Formosa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formosa Pharmaceuticals Inc (TPE:6838) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 57, Fuxing North Road, 8th Floor 6, Songshan District, Taipei, TWN, 105

Website

https://www.formosapharma.com

Formosa Pharmaceuticals Inc. is a late-preclinical and early-clinical-stage biopharmaceutical company with a focus on the indications of ophthalmology, oncology, and anti-infectives.

Formosa Pharmaceuticals Headlines

No Headlines